AllianThera Partners with Dr. Falk Pharma to Develop ATB102 for Ulcerative Colitis
CompanyDeals

AllianThera Partners with Dr. Falk Pharma to Develop ATB102 for Ulcerative Colitis

Grand Pharma Partners with IRE EliT to Distribute 68Ge/68Ga Generators in China
CompanyDeals

Grand Pharma Partners with IRE EliT to Distribute 68Ge/68Ga Generators in China

Lee's Pharma's Socazolimab Approved by NMPA for ES-SCLC First-Line Treatment
CompanyDrug

Lee’s Pharma’s Socazolimab Approved by NMPA for ES-SCLC First-Line Treatment

BrightGene and CR Sanjiu Collaborate on BGM0504 Injection Development and Commercialization
CompanyDeals

BrightGene and CR Sanjiu Collaborate on BGM0504 Injection Development and Commercialization

AbbVie Reports Strong Q2 2025 Results With Immunology Portfolio Leading Growth
Company

AbbVie Reports Strong Q2 2025 Results With Immunology Portfolio Leading Growth

BMS Q2 Earnings Reflect Strategic Investments; Maintains Full-Year Revenue Growth Outlook
Company

BMS Q2 Earnings Reflect Strategic Investments; Maintains Full-Year Revenue Growth Outlook

China's NHSA Issues Rules for Instant Settlement of Medical Insurance Funds
Policy / Regulatory

China’s NHSA Issues Rules for Instant Settlement of Medical Insurance Funds

Hybio and BrightGene Partner on Peptide Raw Material Supply for Global Drug Commercialization
CompanyDeals

Hybio and BrightGene Partner on Peptide Raw Material Supply for Global Drug Commercialization

BeOne Medicines' BGB-16673 Granted PRIME Designation by EMA for Waldenström's Macroglobulinemia
CompanyDrug

BeOne Medicines’ BGB-16673 Granted PRIME Designation by EMA for Waldenström’s Macroglobulinemia

Neurodawn's Subsidiary Receives NMPA Approval for First LHI Treatment RK-4 Injection
CompanyDrug

Neurodawn’s Subsidiary Receives NMPA Approval for First LHI Treatment RK-4 Injection

NMPA Seeks Public Feedback on Draft Regulations for Internet Drug and Medical Device Information Services
Policy / Regulatory

NMPA Seeks Public Feedback on Draft Regulations for Internet Drug and Medical Device Information Services

Haisco's Ciprofol NDA Accepted by FDA: A Milestone for Chinese Anesthesia Innovation
CompanyDrug

Haisco’s Ciprofol NDA Accepted by FDA: A Milestone for Chinese Anesthesia Innovation